f<REFSHEAD>References

<REFS>1.Levine MF, Hartley EJ, Macperson BA, et al. Oral midazolam premedication for children with congenital cyanotic heart disease undergoing cardiac surgery: a comparative study. Can J Anaesth 1993;40:934–8.

2.Rivenes SM, Lewin MB, Stayer SA, et al. Cardiovascular effects of sevoflurane, isoflurane, halothane, and fentanyl-midazolam in children with congenital heart disease: an echocardiographic study of myocardial contractility and hemodynamics. Anesthesiology 2001;94:223–9.

3.Hickey PR, Hansen DD, Wessel DL, et al. Pulmonary and systemic hemodynamic responses to fentanyl in infants. Anesth Analg 1985;64:483–6.

4.Gruber EM, Laussen PC, Casta A, et al. Stress response in infants undergoing cardiac surgery: a randomized study of fentanyl bolus, fentanyl infusion, and fentanyl- midazolam infusion. Anesth Analg 2001;92:882–90.

5.Moore KL. The Cardiovascular System, the Developing Human: Clinically Oriented Embryology, 8th edn. Saunders/Elsevier, Philadelphia, 2008:285–337.

6.Lynch PJ, Jaffe CC. Patent ductus arteriosus. Patrick J. Lynch, medical illustrator; C. Carl Jaffe, MD, cardiologist. Available at: March 31, 2014).

7.Chang AC, Wells W, Jacobs J, et al. Shunt lesions. In: Chang AC, Hanley FL, Wernovsky G, Wessel D (eds) Pediatric Cardiac Intensive Care. Baltimore: Williams & Wilkins, Baltimore, 1998:, pp. 201–232.

8.Moore P, Brook MM. Patent ductus arteriosus and aortopulmonary window. In Allen HD, Driscoll DJ, Shaddy R, Feltes TF (eds.) Moss and Adams’ Heart Disease in Infants, Children, and Adolescents: Including the Fetus and Young Adult, 8th Eedition. Philadelphia; : Lippincott Williams and Wilkins, 2013:, pp. 722–45.

9.Mullins CE, Pagatto L. Patent ductus arteriosus. In: Garson A Jr, Bricker JT, Fisher DJ, Neish SR (eds) The Science and Practice of Pediatric Cardiology, 3rd edn. Williams & Wilkins, Baltimore, : Williams & Wilkins, 1998:, pp. 1181–97.

10. Sekar KC, Corff KE Treatment of patent ductus arteriosus: indomethacin or ibuprofen? J Perinatol 2008;28: S60–S62.

11.Cooley DA, Norman JC. Closure of patent ductus arteriosus. In: Cooley DA, Norman JC (eds) Techniques in Cardiac Surgery. Houston: Texas Medical Press, Houston, 1975:, pp. 10–17.

12. Surgical ligation of a patent ductus arteriosus (PDA) via thoracotomy. Available at: (accessed 31 March 31, 2014).

13.Suematsu Y, Mora BN, Mihaljevic T, del Nido PJ. Totally endoscopic robotic-assisted repair of patent ductus arteriosus and vascular ring in children. Ann Thor Surg 2005;80:2309–13.

14.Lavoie J, Burrows FA, Hansen DD. Video-assisted thoracoscopic surgery for the treatment of congenital cardiac defects in the pediatric population Anesth Analg 1996;82:563–7.

15.Shaw AD, Mitchell JB Anaesthesia for video-assisted thoracoscopic patent ductus arteriosus ligation. Anaesthesia 1998;53:914–7.

16.Uezono S, Hammer GB, Wellis V, et al. Anesthesia for outpatient repair of patent ductus arteriosus. J Cardiothorac Vasc Anesth 2001;15:750–2.

17.Le Bret E, Papadatos S, Folliguet T, et al. Interruption of patent ductus arteriosus in children: robotically assisted versus videothoracoscopic surgery. J Thorac Cardiovasc Surg 2002;123:973–6.

18.Lloyd TR, Fedderly R, Mendelsohn AM, et al. Transcatheter occlusion of patent ductus arteriosus with Gianturco coils. Circulation 1993;88:1412–20.

19.Ebeid MR, Gaymes CH, Smith JC, et al. Gianturco–Grifka vascular occlusion device for closure of patent ductus arteriosus. Am J Cardiol 2001;87:657–660.

20.Pass RH, Hijazi Z, Hsu DT, et al. Multicenter USA Amplatzer patent ductus arteriosus occlusion device trial: initial and one-year results. J Am Coll Cardiol 2004;44:513–9.

21.Prieto LR, DeCamillo DM, Konrad DJ, et al. Comparison of cost and clinical outcome between transcatheter coil occlusion and surgical closure of isolated patent ductus arteriosus. Pediatrics 11998;01:1020–24.

22.Dutta S, Mihailovic A, Benson L, et al. Thoracoscopic ligation versus coil occlusion for patent ductus arteriosus: a matched cohort study of outcomes and cost. Surg Endosc 2008;22:1643–48.

23.Prsa M, Ewert P. (2011) Transcatheter closure of a Patent ductus arteriosus in a preterm infant with an Amplatzer vascular plug IV device. Catheter Cardiovasc Interv. 2011;77:108-–11.

24.Williams RK, Abajian JC. High spinal anaesthesia for repair of patent ductus arteriosus in neonates. Paediatr Anaesth 1997;7:205–9.

25.Lin YC, Sentivany-Collins SK, Peterson KL, et al. Outcomes after single injection caudal epidural versus continuous infusion epidural via caudal approach for postoperative analgesia in infants and children undergoing patent ductus arteriosus ligation. Paediatr Anaesth 1999;9:139–143.

26.Wiggins JW. Aortopulmonary septal defect. In: Garson A Jr, Bricker JT, Fisher DJ, Neish SR . (eds) The Science and Practice of Pediatric Cardiology, 2nd edn. Williams & Wilkins, Baltimore: v, 1998:, pp. 1199–1205.

27.Tanoue Y, Sese A, Ueno Y, Joh K. Surgical management of aortopulmonary window. Jpn J Thorac Cardiovasc Surg 2000;48:557–561.

28.Tkebuchava T, von Segesser LK, Vogt PR. Congenital aortopulumonary window: diagnosis, surgical technique and long-term results. Eur J Cardiothorac Surg 1997;11:293–7.

29.Kutsche LM, Van Mierop LH. Anatomy and pathogenesis of aorticopulmonary septal defect. Am J Cardiol 1987;59:443–7.

30.Backer CL, Mavroudis C. Surgical management of aortopulmonary window: a 40-year experience. Eur J Cardiothorac Surg 2002;21:773–9.

31.Blieden LC, Moller JH. Aorticopulmonary septal defect. An experience with 17 patients. Br Heart J 1974;36:630–5.

32.Erez E, Dagan O, Georghiou GP, et al. Surgical management of aortopulmonary window and associated lesions. Ann Thorac Surg 2004;77:484–7.

33.Tulloh RM, Rigby ML. Transcatheter umbrella closure of aorto-pulmonary window. Heart 1997;77:479–480.

34.Sivakumar K, Francis E. Transcatheter closure of distal aortopulmonary window using Amplatzer device. Cong Heart Dis 2006;1:321–3.

35.Di Bella I, Gladstone DJ. Surgical management of aortopulmonary window. Ann Thorac Surg 1998;65:768–770.

36.Matsuki O, Yagihara T, Yamamoto F, et al. As originally published in 1992: new surgical technique for total-defect aortopulmonary window. Ann Thorac Surg 1999;67:891.

37.Noonan PME, Tarak D, DeGiovanni JV. Closure of an aortopulmonary window using the Amplatzer duct occluder II. Pediatr Cardiol 2013;34:712-–714.

38.Trehan V, Nigam A, Tyagi S. Percutaneous closure of nonrestrictive aortopulmonary window in three infants. Catheterization and Cardiovascular Interventions 2008;71:405-–411.

39.Hagen PT, Sholtz DG, Edwards WD. Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clinic Proceedings 1984;59:17-–20.

40. Porter CJ, Edwards WD. Atrial septal defects, in : Allen HD, Shaddy RE, Driscoll DJ, et al. (eds) Moss and Adam’s Heart Disease in Infants, Children, and Adolescents, Including the Fetus and Young Adult, Seventh 7th ednEdition., Philadelphia; Lippincott, Williams, & Wilkins, 2008:, p. 634.

41. Redmond JM, Lodge AJ. Atrial septal defects and ventricular septal defects.,In: Nichols DG, Ungerleider RM, Spevak PJ, et al. (eds) Critical Heart Disease in Infants and Children, Second 2nd ednEdition. Mosby Elsevier Philadelphia: Mosby Elsevier, 2006:, pp. 580-–90.

42.Vick GW. Defects of the atrial septum including atrioventricular septal defects. In: Garson A Jr, Bricker JT, Fisher DJ, Neish SR (eds) The Science and Practice of Pediatric Cardiology, 2nd edn. Baltimore: Williams & WilkinsWilliams & Wilkins, Baltimore, 1998, pp. :1141–79.

43.Sealy WC, Farmer JC, Young WG, et al. Atrial dysrhythmia and atrial secundum defects. J Thorac Cardiovasc Surg 1969;57:245–250.

44.Reybrouck T, Bisschop A, Dumoulin M, et al. Cardiorespiratory exercise capacity after surgical closure of atrial septal defect is influenced by the age at surgery. Am Heart J 1991;122:1073–78.

45. Backer CL, Mavroudis C. Atrial septal defect, partial anomalous pulmonary venous connection, and scimitar syndrome. In, Mavroudis C, Backer CL (eds). Pediatric Cardiac Surgery, 4th edn4th Edition. Oxford, UK; Wiley-Blackwell; 2013:295-–310.

46.Nicholson IA, Bichell DP, Bacha EA, del Nido PJ. Minimal sternotomy approach for congenital heart operations. Ann Thorac Surg 2001;71:469–472.

47.Khan JH, McElhinney DB, Reddy VM, Hanley FL. A 5-year experience with surgical repair of atrial septal defect employing limited exposure. Cardiol Young 1999;9:572– 576.

48.Black MD, Freedom RM. Minimally invasive repair of atrial septal defects. Ann Thorac Surg 1998;65:765–7.

49.Bonaros N, Schachner T, Oehlinger A, et al. Robotically assisted totally endoscopic atrial septal defect repair: insights from operative times, learning curves, and clinical outcome. Ann Thorac Surg 2006;82:687-–694.

50.Taaffe M, Fischer E, Baranowski A, et al. Comparison of three patent foramen ovale closure devices in a randomized trial (Amplatzer versus CardioSEAL-STARflex versus Helex occluder). Am J Cardiol 2008;101:1353– 1358.

51.Sievert H, Fischer E, Heinisch C, et al. Transcatheter closure of patent foramen ovale without an implant: initial clinical experience. Circulation 2007;116:1701– 1706.

52.Ruiz CE, Kipshidze N, Chiam PT, Gogorishvili I. Feasibility of patent foramen ovale closure with no-device left behind: first-in-man percutaneous suture closure. Catheter Cardiovasc Interv 2008;71:921–6.

53.Boccalandro F, Baptista E, Muench A, et al. Comparison of intracardiac echocardiography versus transesophageal echocardiography guidance for percutaneous transcatheter closure of atrial septal defect. Am J Cardiol 2004;93:437–440.

54.Marie Valente A, Rhodes JF. Current indications and contraindications for transcatheter atrial septal defect and patent foramen ovale device closure. Am Heart J 2007;153:81–84.

55.Peterson KL, DeCampli WM, Pike NA, et al. A report of two hundred twenty cases of regional anesthesia in pediatric cardiac surgery. Anesth Analg 2000;90:1014– 1019.

56.Hammer GB. Regional anesthesia for pediatric cardiac surgery. J Cardiothorac Vasc Anesth 1999;13:210– 213.

57.Humphreys N, Bays SM, Parry AJ, et al. Spinal anesthesia with an indwelling catheter reduces the stress response in pediatric open heart surgery. Anesthesiology 2005;103:1113–20.

58.Weiner MM, Rosenblatt MA, Mittnacht AJNeuraxial anesthesia and timing of heparin administration in patients undergoing surgery for congenital heart disease using cardiopulmonary bypass. J Cardiothorac Vasc Anesth 2012;26:581-–584.

59.Laussen PC, Reid RW, Stene RA, et al. Tracheal extubation of children in the operating room after atrial septal defect repair as part of a clinical practice guideline. Anesth Analg 1996;82:988–993.

60.Lawrence EJ, Nguyen K, Morris SA, et al. Economic and safety implications of introducing fast tracking in congenital heart surgery. Circ Cardiovasc Qual Outcomes 2013;6:201-–207.

61.Minette MS, Sahn DJ Ventricular septal defects. Circulation 2006;114:2190–97.

62.Baptista MJ, Fairbrother UL, Howard CM, et al. Heterotrisomy, a significant contributing factor to ventricular septal defect associated with Down syndrome? Hum Genet 2000;107:476–482.

63. Lynch PJ, Jaffe CC. Types of ventricular septal defects. Available at: (accessed 31 March, 2014).

64.Lun K, Li H, Leung MP, et al. Analysis of indications for surgical closure of subarterial ventricular septal defect without associated aortic cusp prolapse and aortic regurgitation. Am J Cardiol 2001;87:1266–70.

65.Hoffman JI, Rudolph AM, Heymann MA. Pulmonary vascular disease with congenital heart lesions: pathologic features and causes. Circulation 1981;64:873– 877.

66.Gersony WM. Natural history and decision-making in patients with ventricular septal defect. Progress in Pediatric Cardiology 2001;14:125-–132.

67.Moe DG, Guntheroth WG. Spontaneous closure of uncomplicated ventricular septal defect. Am J Cardiol 1987;60:674–8.

68.Ramaciotti C, Vetter JM, Bornemeier RA, Chin AJ. Prevalence, relation to spontaneous closure, and association of muscular ventricular septal defects with other cardiac defects. Am J Cardiol 1995;75:61–65.

69.Penny DJ, Vick GW. Ventricular septal defect. Lancet 2011;377:1103-–1112.

70.Kadner A, Dave H, Dodge-Khatami A, et al. Inferior partial sternotomy for surgical closure of isolated ventricular septal defects in children. Heart Surg Forum 2004;7: E467–E470–70.

71.Wang YQ, Chen RK, Ye WW, et al. Open-heart surgery in 48 patients via a small right anterolateral thoracotomy. Tex Heart Inst J 1999;26:124–8.

72.Burke RP, Michielon G, Wernovsky G. Video-assisted cardioscopy in congenital heart operations. Ann Thorac Surg 1994;58:864–8.

73.Rao V, Freedom RM, Black MD. Minimally invasive surgery with cardioscopy for congenital heart defects. Ann Thorac Surg 1999;68:1742–45.

74.Miyaji K, Hannan RL, Ojito J, et al. Video-assisted cardioscopy for intraventricular repair in congenital heart disease. Ann Thorac Surg 2000;70:730–7.

75.Ishikawa S, Morishita Y, Sato Y, et al. Frequency and operative correction of aortic insufficiency associated with ventricular septal defect. Ann Thorac Surg 1994;57:996– 998.

76.Karpawich PP, Duff DF, Mullins CE, et al. Ventricular septal defect with associated aortic valve insufficiency. Progression of insufficiency and operative results in young children. J Thorac Cardiovasc Surg 1981;82:182– 189.

77.Backer CL, Winters RC, Zales VR, et al. Restrictive ventricular septal defect: how small is too small to close? Ann Thorac Surg 1993;56:1014–18.

78.Hardin JT, Muskett AD, Canter CE, et al. Primary surgical closure of large ventricular septal defects in small infants. Ann Thorac Surg 1992;53:397–401.

79.Lock JE, Block PC, McKay RG, et al. Transcatheter closure of ventricular septal defects. Circulation 1988;78:361-368–8.

80.Waight DJ, Bacha EA, Kahana M, et al. Catheter therapy of Swiss cheese ventricular septal defects using the Amplatzer muscular VSD occluder. Catheter Cardiovasc Interv 2002;55:355–361.

81.Thanopoulos BD, Rigby ML. Outcome of transcatheter closure of muscular ventricular septal defects with the Amplatzer ventricular septal defect occluder. Heart 2005;91:513–6.

82.Holzer R, Balzer D, Cao QL, et al;. Amplatzer Muscular Ventricular Septal Defect Investigators. Device closure of muscular ventricular septal defects using the Amplatzer muscular ventricular septal defect occluder: immediate and mid-term results of a U.S. registry. J Am Coll Cardiol 2004;43:1257–63.

83.Lock JE, Block PC, McKay RG, et al. Transcatheter closure of ventricular septal defects. Circulation 1988;78:361–8.

84.O’Laughlin MP, Mullins CE. Transcatheter occlusion of ventricular septal defect. Cathet Cardiovasc Diagn 1989;17:175–9.

85.Fu YC, Bass J, Amin Z, et al. (2006) Transcatheter closure of perimembranous ventricular septal defects using the new Amplatzer membranous VSD occluder: results of the U.S. phase I trial. J Am Coll Cardiol 2006;47:319-–325.

86.Tzikas A, Ibrahim R, Velasco-Sanchez D, et al. Transcatheter closure of perimembranous ventricular septal defect with the Amplatzer membranous VSD occluder 2: initial world experience and one-year follow-up. Catheterization and Cardiovascular Interventions 2014;83:571-–580.

87.Michel-Behnke I, Ewert P, Koch A, et al. Device closure of ventricular septal defects by hybrid procedures: a multicenter retrospective study. Catheterization and Cardiovascular Interventions Inte 2011;77:242-–251.

88.Sullivan ID. Transcatheter closure of perimembranous ventricular septal defect: is the risk of heart block too high a price? Heart 2007;93:284–6.

89.Malec E, Mroczek T, Pajak J, et al. Results of surgical treatment of congenital heart defects in children with Down’s syndrome. Pediatr Cardiol 1999;20:351–4.

90.Hasegawa N, Oshima M, Kawakami H, Hirano H. Changes in pulmonary tissue of patients with congenital heart disease and Down syndrome: a morphological and histochemical study. Acta Paediatr Jpn 1990;32:60–66.

91.Yamaki S, Horiuchi T, Sekino Y. Quantitative analysis of pulmonary vascular disease in simple cardiac anomalies with the Down syndrome. Am J Cardiol 1983;51:1502– 1506.

92.Chi TP. The pulmonary vascular bed in children with Down syndrome. J Pediatr 1975;86:533–8.

93.Andersen HO, de Leval MR, Tsang VT, et al. Is complete heart block after surgical closure of ventricular septum defects still an issue? Ann Thorac Surg 2006;82:948–956.

94.Eidem BW, Jones C, Cetta F. Unusual association of hypertrophic cardiomyopathy with complete atrioventricular canal defect and Down syndrome. Tex Heart Inst J 2000;27:289–291.

95.Marino B, Digilio MC, Toscano A, et al. Congenital heart diseases in children with Noonan syndrome: an expanded cardiac spectrum with high prevalence of atrioventricular canal. J Pediatr 1999;135:703–6.

96.Jacobs JP, Burke RP, Quintessenza JA, Marvroudis C. Congenital Heart Surgery Nomenclature and Database Project: atrioventricular canal defect. Ann Thorac Surg 2000;69: S36-–S43.

97.Rastelli G, Kirklin JW, Titus JL. Anatomic observations on complete form of persistent common atrioventricular canal with special reference to atrioventricular valves. Mayo Clin Proc 1966;41:296–308.

98.Newfeld EA, Sher M, Paul MH, Nikaidoh H. Pulmonary vascular disease in complete atrioventricular canal defect. Am J Cardiol 1977;39:721–6.

99.Giamberti A, Marino B, di Carlo D, et al. Partial atrioventricular canal with congestive heart failure in the first year of life: surgical options. Ann Thorac Surg 1996;62:151–4.

100.Lange R, Guenther T, Busch R, et al. The presence of Down syndrome is not a risk factor in complete atrioventricular septal defect repair. J Thoracic Cardiovasc Surg 2007;134:304–310.

101.Kado H, Tanoue Y, Fukae K, et al. Does Down syndrome affect the long-term results of complete atrioventricular septal defect when the defect is repaired during the first year of life? Eur J Cardio Thorac Surg 2005;27:405–9.

102.Fudge JC, Li S, Jaggers J, et al. Congenital heart surgery outcomes in Down syndrome: analysis of a national clinical database. Pediatrics 2010;126:315-–322.

103.Singh RR, Warren PS, Reece TB, et al. Early repair of complete atrioventricular septal defect is safe and effective. Ann Thorac Surg 2006;82:1598–1601.

104.Cope JT, Fraser GD, Kouretas PC, Kron IL. Complete versus partial atrioventricular canal: equal risks of repair in the modern era. Ann Surg 2002;236:514–520.

105.Macris MP, Ott DA, Cooley DA. Complete atrioventricular canal defect: surgical considerations.Tex Heart Inst J.1992;19:239-–43.

106.Redmond JM, Silove ED, De Giovanni JV, et al. Complete atrioventricular septal defects: the influence of associated cardiac anomalies on surgical management and outcome. Eur J Cardiothorac Surg 1996;10:991–5.

107.Oshima Y, Yamaguchi M, Yoshimura N, et al. Anatomically corrective repair of complete atrioventricular septal defects and major cardiac anomalies. Ann Thorac Surg 2001;72:424–9.

108.Schaffer R, Berdat P, Stolle B, et al. Surgery of the complete atrioventricular canal: relationship between age at operation, mitral regurgitation, size of the ventricular septum defect, additional malformations and early postoperative outcome. Cardiology 1999;91:231– 235.

109.Hanley FL, Fenton KN, Jonas RA, et al. Surgical repair of complete atrioventricular canal defects in infancy. Twenty-year trends. J Thorac Cardiovasc Surg 1993;106:387– 394.

110.Stark J, Gallivan S, Lovegrove J, et al. Mortality rates after surgery for congenital heart defects in children and surgeons’ performance. Lancet 2000;355:1004–07.

111.Morray JP, Lynn AM, Mansfield PB. Effect of pH and PCO2 on pulmonary and systemic hemodynamics after surgery in children with congenital heart disease and pulmonary hypertension. J Pediatr. 1988;113:474-–9.

112.Trachte AL, Lobato EB, Urdaneta F, et al. Oral sildenafil reduces pulmonary hypertension after cardiac surgery. Ann Thorac Surg 2005;79:194–7.

113.Silka MJ. Double-outlet ventricles. In: Garson A Jr, Bricker JT, Fisher DJ, Neish SR (eds) The Science and Practice of Pediatric Cardiology, 2nd edn. Baltimore: Williams & Wilkins, Williams & Wilkins, Baltimore1998:1505–23.

114.Troise DE, Ranieri L, Arciprete PM. Surgical repair for double outlet right ventricle and intact ventricular septum. Ann Thorac Surg 2001;71:1018–19.

115.Lev M, Bharati S, Meng CC, et al. A concept of double-outlet right ventricle. J Thorac Cardiovasc Surg 1972;64:271-2–81.

116. Anatomic sub-types of double outlet right ventricle. Available at: accessed 31 March 2014. (accessed March, 2014).

117.Kleinert S, Sano T, Weintraub RG, et al. Anatomic features and surgical strategies in double-outlet right ventricle. Circulation 1997;96:1233–39.

118.Belli E, Serraf A, Lacour-Gayet F, et al. Biventricular repair for double-outlet right ventricle. Results and long- term follow-up. Circulation 1998;98: II360–II365.

119.Musumeci F, Shumway S, Lincoln C, Anderson RH. Surgical treatment for double-outlet right ventricle at the Brompton Hospital, 1973 to 1986. J Thorac Cardiovasc Surg 1988;96:278–7.

120.Gedikbasi A, Oztarhan K, Gul A et al. Diagnosis and prognosis in double-outlet right ventricle. Am J Perinatol 2008;25:427-434–34.

121.Takeuchi K, McGowan FX, Jr, Moran AM, et al. Surgical outcome of double-outlet right ventricle with subpulmonary VSD. Ann Thorac Surg 2001;71:49–52.

122.Cil E, Ozme S, Saraclar M, et al. The angiocardiographic analysis of 73 patients with double-outlet right ventricle. Turk J Pediatr 1997;39:27–33.

123.Belli E, Serraf A, Lacour-Gayet F, et al. Double-outlet right ventricle with non-committed ventricular septal defect. Eur J Cardiothorac Surg 1999;15:747–2.

124.Beekman RP, Roest AA, Helbing WA, et al. Spin echo MRI in the evaluation of hearts with a double outlet right ventricle: usefulness and limitations. Magn Reson Imaging 2000;18:245–3.

125. Walters HL, Pacifico AD. Double outlet ventricles, . In: Mavroudis C, Backer CL (eds) (2003) Pediatric Cardiac Surgery, Third Edition3rd edn. Mosby Elsevier, Philadelphia, : Mosby Elsevier, 2003:, pp. 422).

126.Barbero-Marcial ML, Tanamati C. Repair of truncus arteriosus. Adv Card Surg 1998;10:43–73.

127.Brown JW, Ruzmetov M, Okada Y, et al. Truncus arteriosus repair: outcomes, risk factors, reoperation and management. Eur J Cardiothorac Surg 2001;20:221– 227.

128.Williams JM, de Leeuw M, Black MD, et al. Factors associated with outcomes of persistent truncus arteriosus. J Am Coll Cardiol 1999;34:545–3.

129.Goldmuntz E, Clark BJ, Mitchell LE, et al. Frequency of 22q11 deletions in patients with conotruncal defects. J Am Coll Cardiol 1998;32:492–8.

130.Momma K, Ando M, Matsuoka R. Truncus arteriosus communis associated with chromosome 22q11 deletion. J Am Coll Cardiol 1997;30:1067–71.

131.Frohn-Mulder IM, Wesby SE, Bouwhuis C, et al. Chromosome 22q11 deletions in patients with selected outflow tract malformations. Genet Couns 1999;10:35–41.

132.Collett RW, Edwards JE. Persistent truncus arteriosus: a classification according to anatomical types. Surg Clin North Am 1949;29:1245–70.

133.Van Praagh R, Van Praagh S. The anatomy of common aorticopulmonary trunk (truncus arteriosus communis) and its embryologic implications. A study of 57 necropsy cases. Am J Cardiol 1965;l16:406–5.

134. Jacobs ML Congenital Heart Surgery Nomenclature Database Project: truncus arteriosus. Ann Thorac Surg 2000;69:S50-–S55.

135. Brizard CP, Cochrane A, Austin C, et al. Management strategy and long-term outcome for truncus arteriosus. Eur J Cardiothorac Surg 1997;11:687–5.

136. Sojak V, Lugo J, Koolbergen D, Hazekamp M. Surgery for truncus arteriosus.Multimed Man Cardiothorac Surg. 2012 Jan 1;2012:mms011. doi:10.1093/mmcts/mms011.

137..McElhinney DB, Rajasinghe HA, Mora BN, et al. Reinterventions after repair of common arterial trunk in neonates and young infants. J Am Coll Cardiol 2000;35:1317–22.

138.Black MD, Adatia I, Freedom RM. Truncal valve repair: initial experience in neonates. Ann Thorac Surg 1998;65:1737–40.